3rd Apr 2023 11:09
MyHealthChecked PLC - Cardiff-based healthcare company - Posts revenue of GBP22.3 million for 2022, up 36% from GBP16.4 million in 2021. Says the increase is due to the significant demand from top high street pharmacy retailers for Covid lateral flow tests. Pretax profit, however, falls 25% to GBP1.5 million from GBP2.0 million, as sales & marketing costs rise to GBP798,000 from GBP699,000 a year earlier. Says the rise in costs is due to the "increased investment in marketing activities associated with the new and planned product launches". Incurs an additional consideration of GBP987,000 payable on the acquisition of The Genome Store Ltd, compared to none in 2021. Looking ahead, sees steady sales in 2023, and is ready to respond to spikes in demand as the year progresses. Read More
